Overview

This trial is active, not recruiting.

Condition breast cancer
Treatments audio recorded interviews, focus group session, website session, questionnaire
Sponsor M.D. Anderson Cancer Center
Start date February 2013
End date February 2018
Trial size 80 participants
Trial identifier NCT01663870, 2012-0450

Summary

The goal of this research study to learn about breast cancer survivorship and possible ways to improve breast cancer survivorship programs using technology.

Objectives:

Objective 1: Assess breast cancer survivors on the acceptability of and preferences for the integration of patient navigation and an eHealth technology platform to improve care in the Survivorship Clinic at Lyndon B. Johnson Hospital.

Objective 2: Assess clinic stakeholders acceptability of and preferences for the integration of patient navigation and an eHealth technology platform to improve care for breast cancer patients in the Survivorship Clinic at Lyndon B. Johnson Hospital.

United States No locations recruiting
Other Countries No locations recruiting

Study Design

Observational model cohort
Time perspective prospective
Arm
Patients in the LBJ General Hospital Cancer Survivorship Clinic.
audio recorded interviews
Audio recorded interview at beginning of visit and after using HealthATM website.
website session
10-15 minute session with the HealthATM website.
questionnaire Survey
Questionnaire completion at end of audio recorded interview taking about 5 minutes.
Survivorship clinic stakeholders include clinic nurses, physicians, case managers, oncology patient navigators currently working with those in active treatment, information technology support professionals from the Harris County Hospital District (HCHD).
audio recorded interviews
Audio recorded interview at beginning of visit and after using HealthATM website.
focus group session
Focus group session taking 60-90 minutes.
website session
10-15 minute session with the HealthATM website.

Primary Outcomes

Measure
Interview Study of Breast Cancer Survivorship Programs Using Technology
time frame: 1 day

Eligibility Criteria

Male or female participants at least 18 years old.

Inclusion Criteria: 1. Age 18-years or older (survivors and stakeholders) 2. Ability to read and speak English or Spanish (survivors) 3. Ability to read and speak English (stakeholders) 4. Active patient at the LBJ General Hospital Survivorship Clinic (survivors only) 5. Previous cancer diagnosis with no evidence of recurrence at 3 years or greater following initial diagnosis (survivors only) 6. Harris County Hospital District employee offering clinical or administrative support to the LBJGH Cancer Survivorship Clinic (stakeholders only) 7. Cancer survivors who are at least 6 months from diagnosis Exclusion Criteria: 1) None

Additional Information

Official title Integrating Technology and Navigation to Improve Survivorship Care in Underserved Populations
Principal investigator Susan Peterson, PHD, MPH
Description Breast Cancer Survivors: If patient agrees to take part in this study, they will visit the cancer survivorship clinic where the following tests and procedures will be performed: - Patient will have a 30-60 minute interview where they will be asked about cancer-related informational needs, feelings about survivorship care plans, and preferred methods of communication with survivorship clinic staff. - Patient will be asked about whether they would use the internet and other technologies (such as text messages for appointment reminders) as tools in breast cancer survivorship. - Patient will use a web-based tool called HealthATM. HealthATM is a website that is designed to provide information and tools to help patients better manage their health. After 10-15 minute session with the website, patient will be asked about how easy the website was to use and other questions about their session. - Patient will complete a short questionnaire at the end of the interview asking about personal characteristics, how involved they are in their health care, and their attitudes towards the HealthATM website. It should take about 5 minutes to complete this questionnaire. All interviews will be audiorecorded. All audio recordings will be kept for 5 years and then destroyed. All interview data will be stored in password-protected computers and/or locked file cabinets. There will be no personal identifying information connected to patient's interview answers. Length of Study: All of the study procedures will take place at one visit. The visit should last about 60 minutes. This is an investigational study. Up to 40 participants will be enrolled in this study. All will be enrolled at LBJ General Hospital. Clinic Stakeholders: If clinic staff agree to take part in this study, the following tests and procedures will be performed: - Clinic staff will take part in a 60-90 minute focus group session where they will be asked about their feelings about survivorship care plans and if they think web-based eHealth programs would be helpful as tools in breast cancer survivorship. - Clinic staff will be asked about any challenges and barriers they feel are facing the survivorship programs at LBJ. - Clinic staff will use a web-based tool called HealthATM. HealthATM is a website that provides information and tools to help patients better manage their health. After a 10-15 minute session with the website, they will be asked about how easy the website was to use and other questions about their session. All focus group sessions will be audiorecorded. All audio recordings will be kept for 5 years and then destroyed. All focus group data will be stored in password-protected computers and/or locked file cabinets. There will be no personal identifying information connected to your focus group answers. Length of Study: All of the study procedures will take place at one visit. The visit should last about 60 minutes. This is an investigational study. Up to 40 stakeholders will be enrolled in this study. All will be enrolled at LBJ General Hospital.
Trial information was received from ClinicalTrials.gov and was last updated in January 2016.
Information provided to ClinicalTrials.gov by M.D. Anderson Cancer Center.